Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Prenatal genetic testing: content of discussions between obstetric providers and pregnant women.
B A Bernhardt; G Geller; T Doksum; S M Larson; D Roter; N A Holtzman (Profiled Authors: Debra Roter; Susan Larson; Gail Geller)
Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland, USA. bbernhar@welchlink.welch.jhu.edu
Obstetrics and gynecology 1998;91(5 Pt 1):648-55.
OBJECTIVE: To document the content and accuracy of discussions about prenatal genetic testing between obstetric providers and pregnant women. METHODS: The first prenatal visits of 169 pregnant women with 21 obstetricians and 19 certified nurse-midwives were audiotaped and analyzed for whether a discussion of family history or genetic testing took place and if so, its length, content, and accuracy. RESULTS: Family history was discussed in 60% of visits, maternal serum marker screening in 60%, second-trimester ultrasonography for fetal anomalies in 34%, and for women at least 35 years old, amniocentesis or chorionic villus sampling (CVS) in 98%. The length of discussions of genetic testing averaged 2.5 minutes for women younger than 35 years of age and 6.9 minutes for older women. Topics discussed most often were the practical details of testing, the purpose of testing, and the fact that testing is voluntary. Discussions seldom were comprehensive. Obstetricians were more likely to make a recommendation about testing than were nurse-midwives and were less likely to indicate that testing is voluntary. Most women were satisfied with the amount of information, and the majority of women of advanced maternal age had made a decision about amniocentesis or CVS by the end of the visit. CONCLUSION: The information about genetic testing provided in the first prenatal visit is inadequate for ensuring informed autonomous decision-making. Guidelines addressing the content of these discussions should be developed with input from obstetricians, nurse-midwives, genetic counselors, and pregnant women.
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Publications
-
1.
1996S Loader; P Caldwell; A Kozyra; J C Levenkron; C D Boehm; H H Kazazian; P T Rowley
Cystic fibrosis carrier population screening in the primary care setting.
American journal of human genetics 1996;59(1):234-47. -
2.
2002Lanying Li; Yungui Zhou; Junhua Wang; Diana Hu; Morton J Cowan
Prenatal diagnosis and carrier detection for Athabascan severe combined immunodeficiency disease.
Prenatal diagnosis 2002;22(9):763-8. -
3.
2011Suzanne van Landingham; Jessica Bienstock; Elizabeth Wood Denne; Nancy Hueppchen
Beyond the first trimester screen: can we predict who will choose invasive testing?
Genetics in medicine : official journal of the American College of Medical Genetics 2011;13(6):539-44.
Related Topics
Appears in this Publication
Related Experts
Author of this Publication
-
Internal ExpertsPublications
-
187









-
81









-
40









-
111









-
320









-
67










